Indivior PLC (INDV)
NASDAQ:INDV
INDV Stock Chart & Stats
$30.54
--
Market closed
$30.54
--
Day’s Range― - ―
52-Week Range$8.69 - $38.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)3.12M
Market Cap
$3.82B
Enterprise Value$3.97B
Total Cash (Recent Filing)$195.00M
Total Debt (Recent Filing)$351.00M
Price to Earnings (P/E)21.4
Beta0.63
Next Earnings
Apr 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding125,065,240
10 Day Avg. Volume1,489,353
30 Day Avg. Volume3,115,198
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-45.77
Price to Sales (P/S)3.62
P/FCF Ratio-48.23
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue3.20
Enterprise Value/Gross Profit3.98
Enterprise Value/Ebitda13.18
Forecast
1Y Price Target
$50.67Price Target Upside65.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)3.12
Revenue Forecast (FY)$1.16B
Bulls Say, Bears Say
Bulls Say
Capital Structure And Cost DisciplineAnalyst notes that issuing convertible debt to replace higher-cost borrowings and shifting to a leaner commercial model reduces interest expense and improves cash flow flexibility for strategic investments.
Commercial AdoptionAnalyst highlights rising new patient starts and a growing number of active prescribers for SUBLOCADE, indicating accelerating adoption that could sustain revenue growth and strengthen market share.
Patent Protection And Barriers To EntryAnalyst points out lengthy patent protection and manufacturing complexity for SUBLOCADE, which should limit generic competition and preserve a durable runway for sales expansion.
Bears Say
Revenue Headwind From Portfolio SimplificationAnalyst warns that portfolio simplification is expected to reduce reported revenue, creating a near-term headwind to growth and potential pressure on reported results.
Indivior News
INDV FAQ
What was Indivior PLC’s price range in the past 12 months?
Indivior PLC lowest stock price was $8.69 and its highest was $38.00 in the past 12 months.
What is Indivior PLC’s market cap?
Indivior PLC’s market cap is $3.82B.
When is Indivior PLC’s upcoming earnings report date?
Indivior PLC’s upcoming earnings report date is Apr 23, 2026 which is in 11 days.
How were Indivior PLC’s earnings last quarter?
Currently, no data Available
Is Indivior PLC overvalued?
According to Wall Street analysts Indivior PLC’s price is currently Undervalued.
Does Indivior PLC pay dividends?
Indivior PLC does not currently pay dividends.
What is Indivior PLC’s EPS estimate?
Indivior PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Indivior PLC have?
Indivior PLC has 125,065,240 shares outstanding.
What happened to Indivior PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Indivior PLC?
Currently, no hedge funds are holding shares in INDV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Indivior Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$50.67 (65.91% Upside)
$50.67 (65.91% Upside)
Blogger Sentiment
Bullish
INDV Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $31.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.5%
Last 30 Days ▲ 6.7%
Last 30 Days ▲ 6.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
241.61%
12-Months-Change
Fundamentals
Return on Equity
-98.94%
Trailing 12-Months
Asset Growth
-9.13%
Trailing 12-Months
Company Description
Indivior PLC
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
INDV Stock 12 Month Forecast
Average Price Target
$50.67
▲(65.91% Upside)
Technical Analysis
Neurocrine
―
Supernus Pharmaceuticals
―
Teva Pharmaceutical
―
Collegium Pharmaceutical
―
Amneal Pharmaceuticals
―
Ownership Overview
Currently, No data available
---